郭阳;杨莉;金爱;张莹;王旭东;
GUO Yang;YANG Li;JIN Ai;ZHANG Ying;WANG Xudong;Department of Physiology in School of Basic Medicine of Guizhou Medical University;

• 1:贵州医科大学
• 2:贵州医科大学基础医学院生理学教研室

摘要(Abstract)：

目的:观察G蛋白偶联雌激素受体(GPER)特异性抑制剂G15对17β-雌二醇(E2)刺激转化细胞增殖能力的影响及其机制初探。方法:自制乳腺癌细胞,乳腺癌MCF-10A细胞用50 nmol/LE2连续刺激至第13代,以DMSO刺激作为对照(均标记为P13);显微镜观察细胞转化形态,将DMSO及E2处理后的P13分别接种到裸鼠皮下,接种后1周观察接种部位的成瘤情况;将自制乳腺癌细胞分为E2组和10μmol/L G15组,以MCF-7细胞作为阳性对照细胞,用平板克隆形成实验观察细胞的增殖能力。结果:镜下可见P13代MCF-10A细胞接触抑制消失、细胞胞体变大、出现克隆小球,裸鼠乳腺脂肪垫皮下成瘤(7/10),对照无瘤形成;平板克隆实验中,自制乳腺癌细胞、MCF-7细胞与各自阴性对照比较,E2刺激组的增殖加快,差异有统计学意义(P<0.05);与各自E2刺激组比较,G15抑制组增殖能力下降,差异有统计学意义(P<0.05)。结论:GPER介导E2刺激转化细胞增殖能力增加过程。
Objective: To assess the role of inhibitor G15 in G protein-coupled estrogen receptor( GPER) in malignantly transformed mammary epithelial cells. Methods: Non-tumorigenic MCF-10 A mammary epithelial cells were used as the research models. MCF-7 breast cancer cells were used as the positive control in in vitro assay. Model cells were cultured up to the thirteenth passage,marked as P13. The morphology of treated cells was observed under the microscope,and cell proliferation was detected by plate colony formation assay. Then tumorigenicity was detected in nude mice. Results: In cells treated with E2( 50 n M/L),cell contact inhibition disappeared and cell bodies became larger and fusiform. Transformed cells and MCF-7 cells were further stimulated with E2( with DMSO as controls)and cell proliferation greatly increased( P < 0. 01) and this effect could be dramatically suppressed by G15. E2-treated model cells were tumorigenic( 7/10) significantly in nude mice( with controls as0/5). Conclusion: Novel estrogen receptor GPER may be led to promote the proliferation ability of E2-induced transformed cells.

关键词(KeyWords)： 雌激素类;G蛋白偶联雌激素受体;乳腺肿瘤;细胞转化,肿瘤;细胞生长过程
estrogens;G protein-coupled estrogen receptor;breast tumor;cell transformation,neoplasm;cell growth process

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(31360252,31660345)

作者(Author): 郭阳;杨莉;金爱;张莹;王旭东;
GUO Yang;YANG Li;JIN Ai;ZHANG Ying;WANG Xudong;Department of Physiology in School of Basic Medicine of Guizhou Medical University;

Email:

DOI: 10.19367/j.cnki.1000-2707.2018.06.002

参考文献(References)：

• [1]曾佳佳,杨润祥,刘蓉.乳腺癌的靶向治疗研究进展[J].中国生化药物杂志,2016,(1):7-11.
• [2]BINNS C,LOW W Y,LEE M K.Breast cancer:an increasing public health problem in the Asia pacific region[J].Asia Pac J Public Health,2013,25(5):364-367.
• [3]STRM J O,THEODORSSON A,INGBERG E,et al.Ovariectomy and 17β-estradiol replacement in rats and mice:a visual demonstration[J].J Vis Exp,2012,(64):e4013.
• [4]SANTEN R J,YUE W,WANG J P.Estrogen metabolites and breast cancer[J].Steroids,2015,99(Pt A):61-66.
• [5]ZHOU X,WANG S,WANG Z,et al.Estrogen regulates Hippo signaling via GPER in breast cancer[J].J Clin Invest,2015,125(5):2123-3215.
• [6]YIP C H,RHODES A.Estrogen and progesterone receptors in breast cancer[J].Future Oncol,2014,10(14):2293-2301.
• [7]JIA M,DAHLMAN-WRIGHT K,GUSTAFSSON J A.Estrogen receptor alpha and beta in health and disease[J].Best Pract Res Clin Endocrinol Metab,2015,29(4):557-568.
• [8]LAPPANO R,PISANO A,MAGGIOLINI M.GPER Function in Breast Cancer:An Overview[J].Front Endocrinol(Lausanne),2014,(5):66.
• [9]PANDEY D P,LAPPANO R,ALBANITO L,et al.Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF[J].EMBO J,2009,28(5):523-532.
• [10]ARIAZI E A,BRAILOIU E,YERRUM S,et al.The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells[J].Cancer Res,2010,70(3):1184-1194.
• [11]杨莉,朱筑霞,刘晓红,等.钙蛋白酶在乳腺上皮转化细胞对雌激素刺激反应中的作用[J].基础医学与临床,2013,33(7):819-823.
• [12]LU W L,LI H X,QIAN B Y,et al.The clinical characteristics and prognosis of Chinese early stage breast cancer patients:a retrospective study[J].Breast J,2010,16(3):331-333.
• [13]BINNS C,LOW W Y,LEE M K.Breast cancer:an increasing public health problem in the Asia pacific region[J].Asia Pac J Public Health,2013,25(5):364-367.
• [14]谢辛慈,吴佳,潘芬芬,等.雌激素受体与肿瘤发生的研究进展[J].药物生物技术,2015,22(2):156-159.
• [15]HEMACHANDRA L P,PATEL H,CHANDRASENA R E,et al.SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites[J].Cancer Prev Res(Phila),2014,7(5):505-515.
• [16]SCALING A L,PROSSNITZ E R,HATHAWAY H J.GPER mediates estrogen-induced signaling and proliferation in human breast epithelial cells and normal and malignant breast[J].Horm Cancer,2014,5(3):146-160.
• [17]CATALANO S,BARONE I,ANDòS.Rapid estrogen effects on aromatase phosphorylation in breast cancer cells[J].Methods Mol Biol,2014,12(4):155-163.
• [18]KUMAR A,BEAN L A,RANI A,et al.Contribution of estrogen receptor subtypes,ERα,ERβ,and GPER1 in rapid estradiol-mediated enhancement of hippocampal synaptic transmission in mice[J].Hippocampus,2015,25(12):1556-1566.
• [19]YAN Y,LIU H,WEN H,et al.The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells[J].Mol Cell Biochem,2013,378(1-2):1-7.
• [20]WEIENBORN C,IGNATOV T,POEHLMANN A,et al.GPER functions as a tumor suppressor in MCF-7 and SK-BR-3 breast cancer cells[J].J Cancer Res Clin Oncol,2014,140(4):663-671.
• [21]ARIAZI E A,BRAILOIU E,YERRUM S,et al.The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells[J].Cancer Res,2010,70(3):1184-1194.

文章评论(Comment)：